SEC Comment Letter for Nukkleus Inc. (CIK 0001592782) — Aug 14, 2020
Nukkleus Inc. (CIK 0001592782)
Date: Aug. 14, 2020 · CIK: 0001592782 · Accession: 0000000000-20-007522
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
August 14, 2020
Emil Assentato
Chief Executive Officer
Nukkleus Inc.
525 Washington Boulevard
Jersey City, New Jersey 07310
Re:Nukkleus Inc.
Form 10-K for the Fiscal Year Ended September 30, 2019
Filed January 14, 2020
File No. 0-55922
Dear Mr. Assentato:
We issued comments on the above captioned filing on May 11, 2020. On June 3, 2020,
we issued a follow-up letter informing you that those comments remained outstanding and
unresolved, and absent a substantive response, we would act consistent with our obligations
under the federal securities laws.
As you have not provided a substantive response, we are terminating our review and will
take further steps as we deem appropriate. These steps include releasing publicly, through the
agency s EDGAR system, all correspondence, including this letter, relating to the review of your
filing, consistent with the staff s decision to publicly release comment and response letters
relating to disclosure filings it has reviewed.
Please contact Ta Tanisha Meadows at (202) 551-3322 or Bill Thompson at (202) 551-
3344 if you have questions regarding comments on the financial statements and related matters.
Please contact Katherine Bagley at (202) 551-2545 or Lilyanna Peyser at (202) 551- 3222 with
any other questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services